An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
An international phase 3 clinical trial that treated patients with high-risk localized and locally advanced prostate cancer ...
New substudy results showed a 51% lower estimated risk of metastasis or death over time with perioperative apalutamide plus ...
Briganti and colleagues concluded that, together with the main PROTEUS study, the substudy supports 1-year perioperative apalutamide plus ADT as a treatment option for patients with high-risk ...
Prostate-specific membrane antigen (PSMA)-targeted radiopharmaceutical therapy is safe and effective for patients with ...
Prostate cancer treatments carry different risks. Dr. Fernando Bianco argues for informed decisions that balance cancer ...
Dr. Kishore T. A , Senior Consultant, Uro Oncology & Transplant Surgery, Aster Medcity Kochi | A major 1,500-case experience ...
Five-year results from the NRG-GU003 Phase III trial show that a 25-fraction, five-week postoperative radiation schedule ...
TRACE-I: Long-Term Outcomes of PSMA-Guided Salvage Surgery in Recurrent Prostate Cancer / cancer, cancer care, Cancer ...
A new meta-analysis of sixteen randomized controlled trials shows that prehabilitation before radical prostatectomy ...
Salvage radiation after surgery: If PSA rises after surgery, radiation to the area where the prostate was can still be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results